|
Chelsea Therapeutics International, Ltd.
February 13, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Charlotte, North Carolina-based Chelsea Therapeutics International, Ltd. (“Chelsea Therapeutics” or the “Company”) (Nasdaq: CHTP) for potential violations of the federal securities laws. Investors who purchased Chelsea Therapeutics common stock may be affected.
|
|
Groupon, Inc.
February 8, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Chicago, Illinois-based Groupon, Inc. (“Groupon” or the “Company”) (Nasdaq: GRPN) for potential violations of the federal securities laws. Investors who purchased Groupon’s publicly traded securities may be affected.
|
|
Nevsun Resources, Inc.
February 7, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Vancouver, Brittish Columbia-based Nevsun Resources Ltd. (“Nevsun” or the “Company”) (AMEX: NSU) for potential violations of the federal securities laws. Investors who purchased Company securities may be affected.
|
|
K-Sea Transportation Partners L.P.
February 6, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating East Brunswick, New Jersey-based K-Sea Transportation Partners L.P. (“K-Sea” or the “Company”) for potential violations of the federal securities laws. Investors who purchased Company securities between January 30, 2009 and January 27, 2010 (the “Class Period”) may be affected. During the Class Period, K-Sea’s securities traded on the New York Stock Exchange under the symbol “KSP”. K-Sea is now a wholly owned subsidiary of Kirby Corporation, which acquired K-Sea on July 1, 2011.
|
|
Columbia Laboratories, Inc.
February 6, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Livingston, New Jersey-based Columbia Laboratories, Inc. (“Columbia Laboratories” or the “Company”) (Nasdaq: CBRX) for potential violations of the federal securities laws. Investors who purchased Company securities between December 6, 2010 and January 20, 2012 (the “Class Period”) may be affected.
|
|
Hecla Mining Company
February 6, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Coeur D’Alene, Idaho-based Hecla Mining Company (“Hecla” or the “Company”) (NYSE: HL) for potential violations of the federal securities laws. Investors who purchased Company securities between October 26, 2010 and January 11, 2012 (the “Class Period”) may be affected.
|
|
Trans1, Inc.
February 1, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Wilmington, North Carolina-based Trans1 Inc. (“Trans1” or the “Company”) (Nasdaq: TSON) for potential violations of the federal securities laws. Investors who purchased Trans1 securities between February 21, 2008 and October 17, 2011 may be affected.
|
|
Venoco, Inc.
February 1, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating the Board of Directors of Venoco, Inc. (“Venoco” or the “Company”) (NYSE: VQ) for potential breaches of fiduciary duties arising out of a proposed sale of Venoco to Timothy M. Marquez, Venoco’s Chairman and CEO (“Mr. Marquez”), through a wholly owned entity, Denver Parent Corporation.
|
|
Pep Boys - Manny, Moe & Jack
February 1, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating the Board of Directors of Pep Boys – Manny, Moe & Jack (“Pep Boys” or the “Company”) (NYSE: PBY) for potential breaches of fiduciary duties arising out of a proposed acquisition of Pep Boys by The Gores Group. Investors who purchased or acquired Pep Boys publicly traded common stock and continue to hold such common stock may be affected.
|
|
JDA Software Group, Inc.
January 31, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Scottsdale, Arizona-based JDA Software Group, Inc. (“JDA” or “Company”) (Nasdaq: JDAS) for potential violations of the federal securities laws. Investors who purchased JDA’s common stock may be affected.
|
|
Fusion-io, Inc.
January 26, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Salt Lake City, Utah-based Fusion-io, Inc. (“Fusion-io” or “Company”) (NYSE: FIO) for potential violations of the federal securities laws. Investors who purchased Fusion-io’s common stock, including investors in the Company’s November 2011 secondary offering of common stock may be affected.
|
|
Career Education Corp.
January 24, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Career Education Corp. (“Career Education” or “Company”) (Nasdaq: CECO) for potential violations of the federal securities laws. Investors who purchased Career Education common stock may be affected.
|
|
SAIC, Inc.
January 24, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating SAIC, Inc. (“SAIC” or the “Company”) (NYSE: SAI) for potential violations of the federal securities laws. Investors who purchased Company securities between December 2010 and August 2011 may be affected.
|
|
Tesla Motors, Inc.
January 20, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating San Carlos, California-based Tesla Motors Inc. (“Tesla” or “Company”) (Nasdaq: TSLA) for potential violations of the federal securities laws. Investors who purchased Tesla common stock may be affected.
|
|
Kosmos Energy Ltd.
January 17, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Kosmos Energy Ltd. (“Kosmos” or “Company”) (NYSE: KOS) for potential violations of the federal securities laws. Investors who purchased Kosmos common stock, including purchasers or acquirers in its May 2011 Initial Public Offering (“IPO”) may be affected.
|
|
PHH Corporation
January 11, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Mt. Laurel, New Jersey-based PHH Corporation (“PHH” or “Company”) (NYSE: PHH) for potential violations of the federal securities laws. Investors who purchased PHH’s common stock may be affected.
|
|
Health Management Associates, Inc.
January 10, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Naples, Florida-based Health Management Associates, Inc. (“Health Management” or “Company”) (NYSE: HMA) for potential violations of the federal securities laws. Investors who purchased Health Management’s common stock may be affected.
|
|
Integra LifeSciences Holdings Corporation
January 6, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Plainsboro, New Jersey-based Integra LifeSciences Holdings Corporation (“Integra” or “Company”) (Nasdaq: IART) for potential violations of the federal securities laws. Investors who purchased Integra’s common stock since June 2009 may be affected.
|
|
Pacific Biosciences of California, Inc.
December 13, 2011 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Menlo Park, California-based Pacific Biosciences of California, Inc. (“Pacific Biosciences” or the “Company”) (Nasdaq: PACB) for potential violations of the federal securities laws. Investors who purchased Pacific Biosciences’ common stock, including investors who purchased or acquired common stock in the Company’s initial public offering (“IPO”) in October 2010 may be affected.
|
|
Chemed Corp.
November 16, 2011 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Cincinnati, Ohio-based Chemed Corp. (“Chemed” or “Company”) (NYSE: CHR) for potential violations of the federal securities laws. Investors who purchased the Company’s common stock may be affected.
|
|
Jazz Pharmaceuticals, Inc.
October 19, 2011 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Palo, Alto, California-based Jazz Pharmaceuticals Inc. (“Jazz Pharmaceuticals” or “Company”) (Nasdaq: JAZZ) for potential violations of the federal securities laws. Investors who purchased the Company’s common stock may be affected.
|
|
Balance Bar Company
October 14, 2011 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims that the Balance Bar Company deceptively represents its Balance Bar as “All Natural” even though they contain synthetic ingredients.
|
|
In-Home Healthcare Companies – Gentiva Health Services Inc. and LHC Group Inc.
October 5, 2011 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Gentiva Health Services Inc. (Nasdaq: GTIV) and LHC Group, Inc. (Nasdaq: LHCG) for potential violations of the federal securities laws. Investors who purchased securities of the above companies may be affected.
|
|
ZonePerfect Nutrition Company
September 27, 2011 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims that ZonePerfect Nutrition Company (“ZonePerfect”) deceptively labels its ZonePerfect nutrition bars as “All Natural,” when in fact the bars contain one or more ingredients recognized by federal regulations as synthetic chemicals or ingredients, and not “All Natural” as ZonePerfect claims.
|
|
World One Enterprises LLC
September 26, 2011 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims that World One Enterprises LLC deceptively advertises its One Natural Experience Coconut Water (“O.N.E.”) brand of coconut water as a “good source of electrolytes.”.
|
|
Retailer Return Policies
September 1, 2011 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims that retailers such as Costco and Walmart are violating California consumer laws by refusing to pay consumers who return merchandise to their stores, refund tax based on the rate in effect at the time of the sale to consumers.
|
|
Netflix, Inc.
July 26, 2011 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Netflix Inc. (“Netflix” or the “Company”) (Nasdaq: NFLX) for potential violations of the federal securities laws. Investors who purchased Company securities may be affected.
|
|
U.S. Bancorp
July 15, 2011 - Kaplan Fox Investigates Lawsuit for Wage/Overtime and Labor Law Violations Against U.S. Bancorp, U.S. Bank National Association and U.S. Bank Home Mortgage dba U.S. Bank N.A.
|
|
CVS Caremark
July 12, 2011 - Kaplan Fox & Kilsheimer LLP (“Kaplan Fox”) (www.kaplanfox.com) is investigating claims that CVS Caremark (“CVS”) double-bills its customers for the price of prescription drugs using its nationwide billing system.
|
|
Wright Medical Group, Inc.
April 5, 2011 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Wright Medical Group Inc. (“Wright Medical” or the “Company”) (Nasdaq: WMGI) for potential violations of the federal securities laws. Investors who purchased Company securities may be affected.
|
Case Investigations